Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz

All NewsApril 14, 2026

Tempus AI gains as AACR 2026 abstracts highlight biomarkers and cancer subtypes, while Jefferies starts coverage with an Underperform rating.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

US believes Nvidia’s Huang had romantic relationship with alleged Chinese spy

Walmart has a 7-piece comforter set with matching sheets for $35

Albertsons, Safeway forced to make major pharmacy changes after $900 million ruling

Target brings back a holiday benefit that protects shoppers

Elon Musk says Tesla will stop making iconic vehicles